What is DNA Sequencing and Service?
The DNA Sequencing Facility offers reliable, prolonged read, computerized Sanger sequencing with speedy turnaround; microsatellite-based genotyping and fragment analysis; plasmid and BAC DNA practise and purification; and related molecular natural choices which consists of PCR, cloning, sub-cloning, site-directed mutagenesis. DNA sequencing is a technological information in which a number DNA strands can be sequenced via giant parallelization. This sequencing consists of every Sanger’s approach of sequencing and non-Sanger’s techniques of sequencing. Advantages such as low cost, immoderate accuracy & speed, and unique effects even from low sample enter are supplied through way of DNA sequencing over microarray and extraordinary genomic comparison methods. DNA sequencing is used to execute a range of features such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide comparison and consists of substantially modified regular gear of genomics, frequently microarray, genotyping, and others. The demand for DNA sequencing has multiplied significantly, owing to surge in sequencing features and upward jab in technological traits in DNA sequencing.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
Key Companies Profiled | Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Azenta US Inc. (United States), Becton Dickinson and Co. (United States), BGI Group (China), Bio Rad Laboratories Inc. (United States), Danaher Corp. (United States), Eurofins Scientific SE (Luxembourg), F. Hoffmann La Roche Ltd. (Switzerland) and Illumina Inc. (United States) |
CAGR | % |
The market study is broken down, by Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, Forensics and Others) and major geographies with country level break-up.
The DNA sequencing market is fragmented, and the companies are deploying natural and inorganic boom techniques to compete in the market. Companies are attractive in launching modern market options to garner the interest of current and new customers. To make the most of the possibilities and get better from post-pandemic impact, market carriers must focal point greater on the increase potentialities in the fast-growing segments, whilst retaining their positions in the slow-growing segments. Analysts at AMA Research estimates that Players from United States will contribute to the maximum growth of Global DNA Sequencing and Service market throughout the predicted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Azenta US Inc. (United States), Becton Dickinson and Co. (United States), BGI Group (China), Bio Rad Laboratories Inc. (United States), Danaher Corp. (United States), Eurofins Scientific SE (Luxembourg), F. Hoffmann La Roche Ltd. (Switzerland) and Illumina Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Macrogen Inc. (South Korea), Merck KGaA (Germany), Pacific Biosciences of California Inc. (United States) and PerkinElmer Inc. (United States).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global DNA Sequencing and Service market by Type, Application and Region.
On the basis of geography, the market of DNA Sequencing and Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology, the sub-segment i.e. Sequencing by Synthesis will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sequencing, the sub-segment i.e. Sanger Sequencing will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Academic & Government Research Institutes will boost the DNA Sequencing and Service market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In2020, QIAGEN (Netherlands) obtained NeuMoDx Molecular (US) to improve its management role in computerized molecular testing. Medium- and high-throughput NeuMoDx automation options based totally on PCR checking out technological know-how will now be built-in into QIAGEN’s portfolio.
In August 2020, Illumina Inc. launched NovaSeq 6000 v1.5 Reagent Kit, which made the WGS method extra reasonably priced and reachable for all the laboratories and decreased the price to sequence a human genome for USD 600. These new kits can be used throughout WGS, single-cell genomics, and liquid biopsy techniques.
In January 2020, the Department of Biotechnology (DBT) initiated the “Genome India Project” (GIP). The challenge ambitions to gather 10,000 genetic samples from residents throughout India to construct a reference genome. Some of the areas of center of attention of this challenge are precision health, uncommon genetic disorders, mutation spectrum of genetic and complicated ailments in the Indian population, genetic epidemiology of multifactorial way of life diseases, and translational research.
Market Drivers
- Increase in the Incidence of Genetic Disorders and Cancer
- Declining Cost of Genetic Sequencing
- Technological Advancements in Sequencing Techniques
Opportunities
- Use of genomics in specialized/personalized medicine
Restraints
- Lack of Skilled Personnel
- High Costs Incurred In the Establishment and Maintenance of Sequencing Facilities
Challenges
- Inadequate Resources for DNA Sequencing In Developing Countries
Key Target Audience
DNA Sequencing and Service Provider, Academic & Government Research Institutes, Pharmaceutical Companies and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?The standard version of the report profiles players such as Abbott Laboratories (United States), Agilent Technologies Inc. (United States), Azenta US Inc. (United States), Becton Dickinson and Co. (United States), BGI Group (China), Bio Rad Laboratories Inc. (United States), Danaher Corp. (United States), Eurofins Scientific SE (Luxembourg), F. Hoffmann La Roche Ltd. (Switzerland) and Illumina Inc. (United States) etc.
2. Can we have customized study for DNA Sequencing and Service Market? The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of DNA Sequencing and Service Market by 2027?
Analysts at AMA estimates DNA Sequencing and Service Market to reach USD Million by 2027.